# Medical Device Integrity Act: Plain Language Summary

The Medical Device Integrity Act is designed to strengthen the safety and reliability of medical devices that people use or have implanted in their bodies. Right now, there are concerns that some medical devices might have defects or quality problems that aren't being caught or reported quickly enough. This bill aims to tighten the rules around how medical device manufacturers test their products, report problems, and keep track of devices after they're already being used by patients.

The bill would require manufacturers to be more transparent about potential issues with their devices and give regulators better tools to catch problems early. It also establishes clearer requirements for how companies must document and report defects, malfunctions, or safety concerns. This means if a pacemaker, artificial joint, or any other medical device starts showing signs of trouble, there would be a more systematic way to identify it, report it, and take action. The goal is to prevent devices with serious flaws from staying on the market or in patients' bodies longer than necessary.

For patients, this could mean better protection and faster recalls if problems are discovered. For manufacturers, it means stricter compliance requirements and more detailed record-keeping. Healthcare providers would also benefit from having clearer information about device safety issues so they can make better decisions about which products to use. Overall, the bill treats medical device safety as a priority by creating stronger accountability throughout the entire lifecycle of these products, from manufacturing through use in patients.

Medical Device Integrity Act

Baldwin, Tammy

Medical Device Integrity Act This bill provides the Food and Drug Administration (FDA) with the authority to request records and information from an establishment that manufactures or otherwise prepares medical devices. Currently, the FDA only has statutory authority to make such requests to establishments that manufacture or otherwise prepare drugs. The bill also requires the FDA to include in its requests a rationale for requesting the information in question.